Patent · US Active

Stable pharmaceutical compositions of succinylcholine chloride

US11872305B2 · kind B2 · utility

0Cited by
1References
13Claims
0Family size

Inventors

Key dates

Filing dateAug 26, 2022
Grant dateJan 16, 2024
Priority date
Expiry dateAug 26, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/183
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to injectable pharmaceutical compositions comprising therapeutically effective amount of succinylcholine chloride, one or more pharmaceutically acceptable aqueous solvents, and one or more stabilizing agents selected from aliphatic polyols; lower alkyl alcohols; amino acids having at least one additional amino, carboxyl or hydroxyl group; amino alcohols; and aliphatic dicarboxylic acids having at least one hydroxyl or amino group, or α-β unsaturation. The compositions are stable at room temperature for at least 30 days. Methods of manufacturing the injectable pharmaceutical compositions are also provided. The composition may be provided in a sealed container, e.g., an ampoule, vial and pre-filled syringe, and are suitable for subcutaneous, intravenous or intramuscular administration as an adjunct to general anesthesia, to facilitate tracheal intubation, and/or to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.